Superstring Capital Management LP 89bio, Inc. Transaction History
Superstring Capital Management LP
- $114 Billion
- Q3 2024
A detailed history of Superstring Capital Management LP transactions in 89bio, Inc. stock. As of the latest transaction made, Superstring Capital Management LP holds 595,203 shares of ETNB stock, worth $4.67 Million. This represents 3.86% of its overall portfolio holdings.
Number of Shares
595,203
Previous 680,403
12.52%
Holding current value
$4.67 Million
Previous $5.45 Billion
19.18%
% of portfolio
3.86%
Previous 6.87%
Shares
4 transactions
Others Institutions Holding ETNB
# of Institutions
158Shares Held
108MCall Options Held
73.6KPut Options Held
1.19M-
Janus Henderson Group PLC London, X015.2MShares$119 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA14.2MShares$111 Million1.46% of portfolio
-
Suvretta Capital Management, LLC New York, NY7.99MShares$62.7 Million2.33% of portfolio
-
Rtw Investments, LP New York, NY7.38MShares$57.9 Million0.87% of portfolio
-
Black Rock Inc. New York, NY7.02MShares$55.1 Million0.0% of portfolio
About 89bio, Inc.
- Ticker ETNB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,484,500
- Market Cap $365M
- Description
- 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...